| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue | 1,900 | 1,724 | 2,503 | 5,756 | | | Gross Profit | (1,900) | (1,724) | (2,503) | (5,756) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,979 | 2,546 | 1,084 | 1,237 | | Non Recurring |
-
|
-
| 19 | 155 | | Others | 296 | 293 | 192 | 411 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,175) | (4,563) | (3,798) | (7,559) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 347 | (244) | (3,880) | (107,125) | | Earnings Before Interest And Taxes | (3,828) | (4,807) | (7,678) | (114,685) | | Interest Expense | 79 | 4 | (197) | 122 | | Income Before Tax | (3,908) | (4,810) | (7,481) | (114,806) | | Income Tax Expense |
-
|
-
| (846) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,908) | (4,810) | (6,635) | (114,806) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,908) | (4,810) | (6,635) | (114,806) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,908) | ($4,810) | ($6,635) | ($114,806) |
|
0.44% Nasdaq 
Income Statement
